SuperArray Licenses ABI's PCR Tech to Develop, Sell Assays and Reagents | GenomeWeb
NEW YORK (GenomeWeb News) — SuperArray Bioscience has licensed PCR and real-time PCR technologies from Applied Biosystems to develop and market PCR and related reagents, SuperArray said yesterday.
 
Under the non-exclusive agreement, SuperArray said it will market reagents and assay kits for PCR and real-time PCR that use ABI’s SYBR Green and probe-based methods, and will develop real-time PCR reagents and technologies that it will market to researchers.   
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.